Secondary Carcinoma — Trials

Secondary Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

222 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 75
Recruiting: 42
Ph III recruiting: 2
Growth YoY: —
Industry share: 4%
Top sponsor: Guangzhou Medical University
Termination share: 26%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (24)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04232384	Comparison of "Roll-over' Technique With Standard Abdominal Paracentesis in Suspected Peritoneal Carcinomatosis(ROLLON)	terminated	N/A	71	Post Graduate Institute of Medical Education and Research, ChandigarhOTHER	1	Mar 17, 2022	clinicaltrials
NCT02803515	Hyperthermic Intraperitoneal Chemotherapy (HIPEC) : Predictive Marker and Mechanism	terminated	N/A	12	Centre Hospitalier Universitaire de NiceOTHER	1